Compare IRMD & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRMD | USNA |
|---|---|---|
| Founded | 1992 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 397.1M |
| IPO Year | 2014 | 1996 |
| Metric | IRMD | USNA |
|---|---|---|
| Price | $82.78 | $14.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $116.00 | N/A |
| AVG Volume (30 Days) | 78.9K | ★ 177.0K |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | $83,814,000.00 | ★ $1,060,902,000.00 |
| Revenue This Year | $12.38 | $3.90 |
| Revenue Next Year | $11.31 | $6.21 |
| P/E Ratio | $96.43 | ★ N/A |
| Revenue Growth | ★ 14.43 | N/A |
| 52 Week Low | $67.84 | $12.57 |
| 52 Week High | $107.90 | $31.15 |
| Indicator | IRMD | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 34.57 | 45.84 |
| Support Level | $76.95 | $12.57 |
| Resistance Level | $88.93 | $15.75 |
| Average True Range (ATR) | 2.05 | 0.62 |
| MACD | -0.09 | 0.31 |
| Stochastic Oscillator | 21.82 | 62.20 |
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).